메뉴 건너뛰기




Volumn 9, Issue 8, 2002, Pages 799-810

Serotonin reuptake inhibition: An update on current research strategies

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CYCLOHEXYLAMINE DERIVATIVE; DAPOXETINE; DULOXETINE; EMD 95750; FLESINOXAN; FLUOXETINE; FLUVOXAMINE; L 792239; LY 367265; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; NEFAZODONE; PAROXETINE; PINDOLOL; REBOXETINE; ROBALZOTAN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VILAZODONE; YM 35992;

EID: 0036250012     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867024606795     Document Type: Review
Times cited : (87)

References (115)
  • 29
    • 0009060047 scopus 로고    scopus 로고
    • Ed. UK SmithKline Beecham PLC Patent, WO 9903469
    • (1999)
    • Jenner, P.N.1
  • 66
    • 85037019203 scopus 로고    scopus 로고
    • Ed. U Eli Lilly and Co.; 97-301057[792649], 22, 19-2-1997, EP
    • (1997) Patent
    • James, S.P.1
  • 81
    • 85037021358 scopus 로고    scopus 로고
    • Solvay Pharmaceuticals Inc,; Drug development pipeline-flesinoxan; Company Communication, January 10
    • (2001)
  • 83
    • 85037021525 scopus 로고
    • Drug development pipeline: EMD-66352, EMD-77697, EMD-68843, Company Communication, March 09
    • (1995)
    • Merck, E.1
  • 103
    • 85037022967 scopus 로고    scopus 로고
    • Knoll Pharmaceuticals Co.; Nat. Obesity Research Conference review, November 02
    • (2000) News Release
  • 105
    • 85037024782 scopus 로고    scopus 로고
    • Drug reports, Investigational Drugs database


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.